Using manufacturer-sponsored savings cards, eligible patients can get a 28-day supply of insulin for as low as $35 per month at their local Hy-Vee Pharmacy.
The retailer’s common stock will continue to be listed and traded on the NYSE during the 'cure periods,' subject to the company’s compliance with other continued listing requirements.
According to a Bloomberg report, Neal Sample, a consultant and former CIO at Northwestern Mutual, will reportedly help interim CEO Ginger Graham make decisions about new tech initiatives.